CVS Health Corp (CVS) Stake Lessened by Financial Architects Inc

Financial Architects Inc trimmed its holdings in CVS Health Corp (NYSE:CVS) by 77.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,085 shares of the pharmacy operator’s stock after selling 10,471 shares during the quarter. Financial Architects Inc’s holdings in CVS Health were worth $251,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in CVS. Horan Capital Advisors LLC. raised its stake in shares of CVS Health by 3.2% in the second quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock worth $2,584,000 after purchasing an additional 1,000 shares during the last quarter. Community Bank N.A. grew its holdings in shares of CVS Health by 7.3% in the second quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock valued at $1,608,000 after acquiring an additional 1,362 shares in the last quarter. FIL Ltd grew its holdings in shares of CVS Health by 13.8% in the second quarter. FIL Ltd now owns 514,836 shares of the pharmacy operator’s stock valued at $41,424,000 after acquiring an additional 62,318 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in shares of CVS Health by 3.2% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock valued at $13,840,000 after acquiring an additional 5,478 shares in the last quarter. Finally, Midwest Investment Management LLC grew its holdings in shares of CVS Health by 6.2% in the second quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock valued at $1,720,000 after acquiring an additional 1,245 shares in the last quarter. 81.63% of the stock is currently owned by institutional investors.

Shares of CVS Health Corp (NYSE CVS) opened at $73.41 on Friday. The stock has a market capitalization of $75,609.72, a price-to-earnings ratio of 15.17, a price-to-earnings-growth ratio of 1.40 and a beta of 0.89. CVS Health Corp has a 12-month low of $66.45 and a 12-month high of $84.72. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.01. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The company had revenue of $46.18 billion for the quarter, compared to the consensus estimate of $46.17 billion. During the same quarter last year, the business posted $1.64 earnings per share. The firm’s revenue was up 3.5% compared to the same quarter last year. sell-side analysts forecast that CVS Health Corp will post 5.9 EPS for the current year.

In related news, EVP Thomas M. Moriarty sold 20,547 shares of the stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total value of $1,667,799.99. Following the sale, the executive vice president now owns 43,178 shares in the company, valued at $3,504,758.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Lisa Bisaccia sold 29,445 shares of the stock in a transaction on Thursday, December 21st. The stock was sold at an average price of $75.00, for a total value of $2,208,375.00. Following the completion of the sale, the executive vice president now owns 15,556 shares in the company, valued at approximately $1,166,700. The disclosure for this sale can be found here. Company insiders own 0.61% of the company’s stock.

Several equities analysts have weighed in on the company. Robert W. Baird set a $77.00 price objective on CVS Health and gave the company a “hold” rating in a report on Monday, December 4th. Jefferies Group set a $76.00 price objective on CVS Health and gave the company a “hold” rating in a report on Monday, December 4th. Loop Capital set a $73.00 price objective on CVS Health and gave the company a “hold” rating in a report on Monday, December 4th. Royal Bank of Canada initiated coverage on CVS Health in a report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price objective for the company. Finally, Leerink Swann restated an “outperform” rating and set a $85.00 target price (down previously from $90.00) on shares of CVS Health in a research report on Tuesday, November 7th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the stock. CVS Health presently has a consensus rating of “Buy” and an average target price of $86.35.

COPYRIGHT VIOLATION WARNING: “CVS Health Corp (CVS) Stake Lessened by Financial Architects Inc” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright legislation. The legal version of this piece can be accessed at https://www.com-unik.info/2017/12/24/cvs-health-corp-cvs-stake-lessened-by-financial-architects-inc.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit